Human Cytomegalovirus Cmv

Cytomegalovirus (CMV), Antibody

GWB-3DA3A6 GenWay Biotech 1 mg Ask for price

Cytomegalovirus Antibody Laboratories manufactures the human cytomegalovirus cmv reagents distributed by Genprice. The Human Cytomegalovirus Cmv reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact cytomegalovirus Antibody. Other Human products are available in stock. Specificity: Human Category: Cytomegalovirus Group: Cmv

Cytomegalovirus (CMV) gB, Antibody

GenWay Biotech 0.1 mg Ask for price

Cytomegalovirus Antibody / CMV / PP65

NSJ Bioreagents 100 ug 424.15 EUR
Description: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop Cytomegalovirus infections. In some patients with AIDS, the virus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of the disease. An indicator of active infection is needed to facilitate the diagnosis of cytomgalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus was detected in the leukocytes of both the peripheral blood and BALF during the early phase of the disease.

Cytomegalovirus Antibody / CMV / PP65

NSJ Bioreagents 20 ug 186.15 EUR
Description: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop Cytomegalovirus infections. In some patients with AIDS, the virus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of the disease. An indicator of active infection is needed to facilitate the diagnosis of cytomgalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus was detected in the leukocytes of both the peripheral blood and BALF during the early phase of the disease.

Cytomegalovirus Antibody / CMV / PP65

NSJ Bioreagents 100 ug 424.15 EUR
Description: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop Cytomegalovirus infections. In some patients with AIDS, the virus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of the disease. An indicator of active infection is needed to facilitate the diagnosis of cytomgalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus was detected in the leukocytes of both the peripheral blood and BALF during the early phase of the disease.

Cytomegalovirus Antibody / CMV / PP65

NSJ Bioreagents 100 ug 424.15 EUR
Description: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop cytomegalovirus (CMV) infections. In some patients with AIDS, cytomegalovirus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of cytomegalovirus disease. An indicator of active CMV infection is needed to facilitate the diagnosis of cytomegalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus p65 antigen was detected in the leukocytes of both the peripheral blood and BALF during the early phase of CMV disease.

Cytomegalovirus Antibody / CMV / PP65

NSJ Bioreagents 20 ug 186.15 EUR
Description: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop cytomegalovirus (CMV) infections. In some patients with AIDS, cytomegalovirus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of cytomegalovirus disease. An indicator of active CMV infection is needed to facilitate the diagnosis of cytomegalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus p65 antigen was detected in the leukocytes of both the peripheral blood and BALF during the early phase of CMV disease.

Cytomegalovirus Antibody / CMV / PP65

NSJ Bioreagents 100 ug 424.15 EUR
Description: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop cytomegalovirus (CMV) infections. In some patients with AIDS, cytomegalovirus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of cytomegalovirus disease. An indicator of active CMV infection is needed to facilitate the diagnosis of cytomegalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus p65 antigen was detected in the leukocytes of both the peripheral blood and BALF during the early phase of CMV disease.

Cmv information

Virus Cytomegalovirus (CMV) Protein

abx670257-1ml Abbexa 1 ml 493.2 EUR

Cytomegalovirus (CMV) IgG ELISA Kit

K4150-100 Biovision each 646.8 EUR

Cytomegalovirus (CMV) IgM ELISA Kit

K4151-100 Biovision each 646.8 EUR

Cytomegalovirus gH (CMV gH) Antibody

abx415688-01mg Abbexa 0.1 mg 777.6 EUR

Cytomegalovirus (CMV) gp B, Antibody

GWB-B9CB2E GenWay Biotech 0.1 mg Ask for price

Human Cytomegalovirus (CMV) IgG ELISA Kit (Direct EIA)

EK7032 BosterBio 96wells/kit, with removable strips. 573.6 EUR

Human Cytomegalovirus (CMV) IgM ELISA Kit (Direct EIA)

EK7033 BosterBio 96wells/kit, with removable strips. 573.6 EUR

Mouse Cytomegalovirus (CMV) ELISA Kit

SL0952Mo Sunlong - Ask for price

Human Cytomegalovirus pp65(CMV pp65) Elisa Kit

EK711662 AFG Bioscience LLC 96 Wells 0.19 EUR

Human Cytomegalovirus pp65 (CMV pp65) ELISA Kit

SL2117Hu Sunlong 96 Tests 468 EUR

Chicken Cytomegalovirus (CMV)ELISA Kit

SL0197Ch Sunlong - Ask for price

Cytomegalovirus Antibody / CMV / PP65

V2332-100UG NSJ Bioreagents 100 ug 424.15 EUR
Description: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop Cytomegalovirus infections. In some patients with AIDS, the virus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of the disease. An indicator of active infection is needed to facilitate the diagnosis of cytomgalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus was detected in the leukocytes of both the peripheral blood and BALF during the early phase of the disease.

Cytomegalovirus Antibody / CMV / PP65

V2332-20UG NSJ Bioreagents 20 ug 186.15 EUR
Description: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop Cytomegalovirus infections. In some patients with AIDS, the virus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of the disease. An indicator of active infection is needed to facilitate the diagnosis of cytomgalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus was detected in the leukocytes of both the peripheral blood and BALF during the early phase of the disease.

Cytomegalovirus Antibody / CMV / PP65

V2332SAF-100UG NSJ Bioreagents 100 ug 424.15 EUR
Description: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop Cytomegalovirus infections. In some patients with AIDS, the virus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of the disease. An indicator of active infection is needed to facilitate the diagnosis of cytomgalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus was detected in the leukocytes of both the peripheral blood and BALF during the early phase of the disease.

Cytomegalovirus Antibody / CMV / PP65

V2333-100UG NSJ Bioreagents 100 ug 424.15 EUR
Description: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop cytomegalovirus (CMV) infections. In some patients with AIDS, cytomegalovirus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of cytomegalovirus disease. An indicator of active CMV infection is needed to facilitate the diagnosis of cytomegalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus p65 antigen was detected in the leukocytes of both the peripheral blood and BALF during the early phase of CMV disease.

Cytomegalovirus Antibody / CMV / PP65

V2333-20UG NSJ Bioreagents 20 ug 186.15 EUR
Description: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop cytomegalovirus (CMV) infections. In some patients with AIDS, cytomegalovirus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of cytomegalovirus disease. An indicator of active CMV infection is needed to facilitate the diagnosis of cytomegalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus p65 antigen was detected in the leukocytes of both the peripheral blood and BALF during the early phase of CMV disease.

Cytomegalovirus Antibody / CMV / PP65

V2333SAF-100UG NSJ Bioreagents 100 ug 424.15 EUR
Description: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop cytomegalovirus (CMV) infections. In some patients with AIDS, cytomegalovirus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of cytomegalovirus disease. An indicator of active CMV infection is needed to facilitate the diagnosis of cytomegalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus p65 antigen was detected in the leukocytes of both the peripheral blood and BALF during the early phase of CMV disease.